Henriette Ingrid Melzer
Overview
Explore the profile of Henriette Ingrid Melzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fendler W, Melzer H, Walz C, von Schweinitz D, Coppenrath E, Schmid I, et al.
Eur J Nucl Med Mol Imaging
. 2013 Jul;
40(11):1701-10.
PMID: 23857458
Purpose: Scintigraphy using (123)I-metaiodobenzylguanidine ((123)I-MIBG) is widely used for the detection of neuroblastic tumours. The aim of this study was to identify a possible correlation between the uptake intensity on...
2.
Mueller W, Melzer H, Schmid I, Coppenrath E, Bartenstein P, Pfluger T
Eur J Nucl Med Mol Imaging
. 2012 Oct;
40(3):356-63.
PMID: 23096080
Purpose: To analyse the diagnostic value of (18)F-FDG PET and MRI for the evaluation of active lesions in paediatric Langerhans cell histiocytosis. Methods: We compared 21 (18)F-FDG PET scans with...
3.
Melzer H, Coppenrath E, Schmid I, Albert M, von Schweinitz D, Tudball C, et al.
Eur J Nucl Med Mol Imaging
. 2011 May;
38(9):1648-58.
PMID: 21617976
Purpose: To analyse different uptake patterns in (123)I-MIBG scintigraphy/SPECT imaging and (18)F-FDG PET in paediatric neuroblastoma patients. Methods: We compared 23 (123)I-MIBG scintigraphy scans and 23 (18)F-FDG PET scans (mean...
4.
Pfluger T, Melzer H, Schneider V, Fougere C, Coppenrath E, Berking C, et al.
Eur J Nucl Med Mol Imaging
. 2011 Jan;
38(5):822-31.
PMID: 21210112
Purpose: The aim of this study was to evaluate the diagnostic value of contrast-enhanced CT (CECT) versus non-enhanced low-dose CT (NECT) in the staging of advanced malignant melanoma with (18)F-fluordeoxyglucose...